Agreement signedPublished 27 Jul 2022

SomaLogic /
Palamedrix

SomaLogic agrees to combine with Palamedrix in merger transaction

Price
$14.0m
Stage
Agreement signed
Source · 27 Jul 2022
01 / BuyerSomaLogic
02 / TargetPalamedrix
01

What happened

SomaLogic, Inc. entered into an agreement to merge with Palamedrix, Inc. on July 25, 2022. Palamedrix will become a wholly owned subsidiary of SomaLogic following the mergers.

The upfront consideration includes approximately $14.0 million in cash and $21.0 million in SomaLogic common stock. Certain Palamedrix securityholders may also receive up to an additional $17.5 million in milestone payments.

02

The source

Everything on this page comes from the source below.

01
Source · Source

SomaLogic agrees to combine with Palamedrix in merger transaction

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.